CECI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 366
EU - Europa 168
AS - Asia 63
AF - Africa 3
OC - Oceania 3
SA - Sud America 2
Totale 605
Nazione #
US - Stati Uniti d'America 361
IT - Italia 77
FR - Francia 30
CN - Cina 22
VN - Vietnam 14
DE - Germania 11
CZ - Repubblica Ceca 8
MK - Macedonia 8
FI - Finlandia 6
CA - Canada 5
JP - Giappone 5
IN - India 4
NL - Olanda 4
TR - Turchia 4
UA - Ucraina 4
DK - Danimarca 3
IR - Iran 3
KR - Corea 3
NO - Norvegia 3
PL - Polonia 3
ZA - Sudafrica 3
AR - Argentina 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
ES - Italia 2
GB - Regno Unito 2
HK - Hong Kong 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 605
Città #
Fairfield 43
Torino 34
Santa Cruz 32
Seattle 27
Houston 22
Woodbridge 21
Ashburn 20
Cambridge 14
Buffalo 13
Dong Ket 13
Ann Arbor 11
Wilmington 10
Helsinki 6
Turin 6
Austin 4
Beijing 4
Castelletto 4
Guangzhou 4
Las Vegas 4
Skopje 4
Chicago 3
Lake Forest 3
Muizenberg 3
San Diego 3
Tokyo 3
Bietigheim-bissingen 2
Boardman 2
Bursa 2
Cadoneghe 2
Clearwater 2
Dortmund 2
Duarte 2
Federal 2
Fleming Island 2
Los Angeles 2
Milan 2
Mountain View 2
Northport 2
Northridge 2
Norwalk 2
Oslo 2
Pisa 2
Portland 2
Prilep 2
Redmond 2
Rockville 2
San Rafael 2
Shanghai 2
Tacoma 2
Toronto 2
Vaprio d'Adda 2
Warsaw 2
Aarhus 1
Amersfoort 1
Auburn 1
Baltimore 1
Bangalore 1
Bengaluru 1
Brockport 1
Catania 1
Cesena 1
Changchun 1
Changsha 1
Chengdu 1
Chiari 1
Cleveland 1
Columbus 1
Dallas 1
Denver 1
Deventer 1
Dresden 1
Eden Prairie 1
Erlangen 1
Fitzroy 1
Fjerritslev 1
Frankfurt am Main 1
Greenville 1
Hamilton 1
Herndon 1
Katowice 1
Keelung 1
Kirkland 1
Lansdale 1
Lanzhou 1
Lihue 1
Lombard 1
Lynden 1
Mcallen 1
Milpitas 1
Montréal 1
Nanjing 1
New Kensington 1
New York 1
Noeux-les-mines 1
Odense 1
Osaka 1
Oshawa 1
Ottawa 1
Padova 1
Palo Alto 1
Totale 413
Nome #
Comparison of68Ga-PSMA-11 PET/CT and18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence, file e27ce42d-ac58-2581-e053-d805fe0acbaa 181
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival, file e27ce42f-d711-2581-e053-d805fe0acbaa 142
18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging, file e27ce430-fea4-2581-e053-d805fe0acbaa 99
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial, file e27ce431-238e-2581-e053-d805fe0acbaa 57
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma, file e27ce433-1895-2581-e053-d805fe0acbaa 44
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor, file e27ce434-df17-2581-e053-d805fe0acbaa 16
Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database, file e27ce430-e98e-2581-e053-d805fe0acbaa 12
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy, file e27ce435-001f-2581-e053-d805fe0acbaa 11
Focal Therapy for Prostate Cancer: Complications and Their Treatment, file e27ce433-fbc0-2581-e053-d805fe0acbaa 6
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?, file e27ce434-18b8-2581-e053-d805fe0acbaa 6
Assessment of health-related quality of life in patients with advanced prostate cancer—current state and future perspectives, file 9ca40c2c-267b-4b81-b0ed-c765fb3726d4 4
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series, file e27ce432-591b-2581-e053-d805fe0acbaa 4
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review, file 39f129ed-183c-48d3-aef0-1154f22fa167 3
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review, file c7e710ab-dc8d-414d-aefc-2b85c8ce8d4c 3
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: Impact on salvage radiotherapy planning, file e27ce42d-ab4b-2581-e053-d805fe0acbaa 3
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review, file e27ce432-16fd-2581-e053-d805fe0acbaa 3
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series, file e27ce42d-9130-2581-e053-d805fe0acbaa 2
Detection of sarcomatoid lung metastasis with 68GA-PSMA PET/CT in a patient with prostate cancer, file e27ce42d-9133-2581-e053-d805fe0acbaa 2
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy, file e27ce42d-9134-2581-e053-d805fe0acbaa 2
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy., file e27ce42d-a045-2581-e053-d805fe0acbaa 2
Comparison of68Ga-PSMA-11 PET/CT and18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence, file e27ce432-5b1b-2581-e053-d805fe0acbaa 2
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy, file e27ce432-60b4-2581-e053-d805fe0acbaa 2
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: Impact on salvage radiotherapy planning, file e27ce432-60b6-2581-e053-d805fe0acbaa 2
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis, file 6b08d997-f6e1-445d-be60-59bb17c0a18d 1
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer, file e27ce42d-912f-2581-e053-d805fe0acbaa 1
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial, file e27ce42d-9d37-2581-e053-d805fe0acbaa 1
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?, file e27ce42d-9d38-2581-e053-d805fe0acbaa 1
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer, file e27ce42d-c652-2581-e053-d805fe0acbaa 1
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?, file e27ce431-2048-2581-e053-d805fe0acbaa 1
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy, file e27ce431-2dd3-2581-e053-d805fe0acbaa 1
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions, file e27ce432-4845-2581-e053-d805fe0acbaa 1
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy, file e27ce432-592e-2581-e053-d805fe0acbaa 1
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?, file e27ce432-5b1a-2581-e053-d805fe0acbaa 1
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence, file e27ce432-60b5-2581-e053-d805fe0acbaa 1
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: A systematic review of population-based evidence, file e27ce433-dda9-2581-e053-d805fe0acbaa 1
Totale 620
Categoria #
all - tutte 1.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201922 0 0 0 0 0 0 0 0 0 14 5 3
2019/202070 0 1 0 1 1 1 4 5 9 9 32 7
2020/2021184 8 7 11 10 11 10 50 20 16 8 7 26
2021/2022189 17 10 3 14 22 7 17 7 12 25 35 20
2022/2023102 3 10 31 23 7 5 6 4 1 3 9 0
2023/202453 1 3 3 4 3 3 16 10 5 5 0 0
Totale 620